Healthy Skepticism Library item: 10437
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Harvey KJ, Harris AH, Bulfone L.
The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?
Med J Aust 2007 Jun 13; 187:(4):206-207
http://www.mja.com.au/public/issues/187_04_200807/har10641_fm.html
Abstract:
Reform is needed, but will the current Bill enact the best options?
Two articles in this issue of the Journal 1,2 comment on a complex but important piece of legislation put forward by the Minister for Health and Ageing – the National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007 (the Bill).3
The Bill splits the Pharmaceutical Benefits Schedule into two formularies: “one part for single brand drugs [F1], the other part for drugs that have multiple brands or that are interchangeable at the patient level with drugs with multiple brands [F2]â€.3 The Bill allows reference pricing of drugs within each formulary but disallows an ongoing link in the price of drugs between formularies…
Notes:
Free full text
